Loss of Progesterone Receptor Expression in Estrogen Receptor Positive Breast Cancer is Associated with HER-2/neu Overexpression

Kunwei Shen
2006-01-01
Tumori
Abstract:Objective:This research is to evaluate the association between status of progesterone receptor (PgR) and cur- rently established clinical and pathological prognostic factors,including HER-2/neu expression level in estrogen receptor (ER) positive breast cancer.Methods:Database of Breast Surgery in Cancer Hospital Fudan University from June,2002 to June,2005 was obtained,and data from 912 female breast cancer cases with ER positive breast cancer and complete clinical and pathological records were then selected for the retrospective analysis.The median age of this group of patients was 53 yr,varying from 24 to 87.in which 360 (39.5%) patients were younger than 50 yr,while the rest 552(60.5%)eases were elder and equal to 50 yr.Im- munohistochemistry(IHC) was used to test protein expression status of ER,PgR and HER-2/neu gene.SPSS-10.0 was used for statistic analysis.Results:Multi-factor analysis showed that over-expression of HER-2/neu,low expression of ER,age≥50 yr and lymph node positive status were independent predictive facts for PgR negative status in ER~+ breast cancer.ER~+/PgR~- breast cancers were more likely over-expression of HER-2/neu compared with ER~+ /PgR~+ cases(12.8% vs 5.8%);Among a small pro- portion (8.0%) of cases in this group which over-express HER-2/neu gene (IHC+++),50.7% cases lost the expression of PgR.while among those with no HER-2/neu gene over-expression (IHC-,+to++),only 29.9% of cases lost PgR expres- sion,the difference was highly significant (P<0.001) Conclusions:Loss of PgR expression in ER~+ breast cancer is significantly associated with HER-2/neu over-expression.
What problem does this paper attempt to address?